|
 Present 
| Now in its sixth year, the rEVOLUTION Symposium has become the place to discuss the most important strategic problems facing pharma and biotech CSOs. We will be examining the organization and management of R&D to uncover new models, some radical, to accelerate the discovery and development of new drugs. | | Date: | March 9 - 11, 2011 | | Location: | Four Seasons Hotel Washington, D.C.
2800 Pennsylvania Avenue N.W.
Washington, D.C. 20007 | | | Schedule: | | Day One | | | 3:00 - 5:30 PM | Registration | | 5:30 PM | Cocktail Reception | | 7:00 PM | Welcome Dinner
| | Day Two | | | 7:00 AM | Breakfast & Registration | | 8:00 AM - 12:00 PM | Business Program | | Afternoon | Activities | | 6:00 - 7:30 PM | Business Program | | 7:30 - 9:30 PM | Reception & Dinner with Guest Speaker | | Day Three | | | 7:00 AM | Breakfast & Registration | | 8:00 AM - 12:00 PM | Business Program | | 12:00 PM - 2:00 PM | Lunch & Departure | | | Information: | Invitation only. For more information, please contact (650) 320-4529. | | | The 2011 distinguished steering committee members include: | | Roger Longman
| Richard DiMarchi, Ph.D.
Indiana University | Elliot Ehrich, M.D.
Alkermes, Inc. | Anthony Ford-Hutchinson, M.D.
Merck & Company, Inc. | David Lacey, M.D., Ph.D.
Amgen, Inc. | Joan Bell, Ph.D.
Novartis Research | Martin Mackay, Ph.D.
Astra Zeneca | Mikael Dolsten, M.D., Ph.D.
Pfizer, Inc. | Tachi Yamada, M.D., Ph.D.
Bill & Melinda Gates Foundation | Lee E. Babiss, Ph.D.
Pharmaceutical Product Development, Inc. | Michel Pairet, DVM, Ph.D.
Boehringer Ingelheim | Oren Cohen, M.D.
Quintiles | Wolfgang Rettig, M.D.
Boehringer Ingelheim | Hal Barron, M.D.
Roche (Genentech) | Elliott Sigal, M.D., Ph.D.
Bristol-Myers Squibb | Gianni Gromo, M.D., Ph.D.
Roche | Thomas O. Daniel, M.D., Ph.D.
Celgene Corporation | Michael Varney, Ph.D.
Roche (Genentech) | Michael Morrissey, Ph.D.
Exelixis, Inc. | Gianni Gromo, M.D., Ph.D.
The Scripps Research Institute | William Chin, M.D.
Harvard University | | | | | | | | |
|